By Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise…
Browsing Tag
Research/Development
13 posts
Where the Cannabis C-Suite is Missing The Mark on Automation – Cannabis Business Executive – Cannabis and Marijuana industry news
Where the Cannabis C-Suite is Missing The Mark on…
Novartis Says Kidney Drug Phase 3 Trial Reaches Positive Interim Result
By Adria Calatayud Novartis said an interim analysis from a phase 3…
Roche Lung Cancer Drug Shows Promise in Phase 3 Trial
By David Sachs Roche said Friday that its Alecensa drug demonstrated the…
ServiceNow Posts Strong Earnings and Adds New AI Tools. But the Stock Is Lower.
This copy is for your personal, non-commercial use only. To order presentation-ready…
Biogen wins accelerated FDA approval for treatment for rare form of ALS
The U.S. Food and Drug Administration said Tuesday it has granted accelerated…
FDA pulls preterm-birth drug Makena and its generics from market after 12 years
The U.S. Food and Drug Administration said Thursday it had reached a…
Disney eliminates metaverse division in cost-cutting purge: report
The metaverse is among the first victims of Walt Disney Co.’s cost-cutting…
Arlington Capital Partners Announces Formation of Eqlipse Technologies
New platform delivers capabilities across full-spectrum cyber and SIGINT engineering, digital operations…
BioVie Shares jump Premarket on Parkinson’s, Alzheimer’s Studies >BIVI
By Colin Kellaher Shares of BioVie Inc. rose sharply in premarket trading…
GSK Says Dreamm-3 Phase 3 Study For Blenrep Didn’t Meet Primary Endpoint
By Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3…
Moderna Stock Takes Off on Cancer Vaccine News
Moderna stock shot up after Merck said it is exercising an option…
YourEncore® Joins AARP® Employer Pledge Program
National effort helps employers solve staffing challenges, directs job seekers to employers…